Rheumatoid Arthritis Linked to Increased Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease

Strategic Insights -

Research on the relationship between rheumatoid arthritis (RA) and metabolic dysfunction-associated steatotic liver disease (MASLD) has revealed a significant association between the two conditions. A population-based study conducted in Austria analyzed data from 6638 participants, including 187 individuals with physician-diagnosed RA. The study found that MASLD prevalence was higher in RA patients than controls (41.2% vs. 28.5%). The research suggests that systematic liver assessment should be considered in the routine care of RA patients.

Key Takeaways:

  • The study analyzed data from 6638 participants, including 187 individuals with physician-diagnosed RA, in a population-based study in Austria.
  • MASLD prevalence was higher in RA patients than controls, with a significant difference observed between the two groups (41.2% vs. 28.5%).
  • The study found that RA was independently associated with MASLD, indicating that the relationship between the two conditions is not solely driven by shared risk factors.
  • The research suggests that systematic liver assessment should be considered in the routine care of RA patients.
  • The study used Poisson regression models with sequential adjustment for demographic factors, metabolic syndrome, lifestyle factors, NSAID use, and cardiovascular risk (SCORE2) to assess the relationship between RA and MASLD.
  • The study also used the Fibrosis-4 Index (FIB-4) to assess liver fibrosis risk.

Statistics:

  • 6638 participants were included in the study.
  • 187 individuals with physician-diagnosed RA were included in the study.
  • MASLD prevalence was 41.2% in RA patients and 28.5% in controls.
  • The study used Poisson regression models to adjust for demographic factors, metabolic syndrome, lifestyle factors, NSAID use, and cardiovascular risk (SCORE2).
  • The study used the Fibrosis-4 Index (FIB-4) to assess liver fibrosis risk.

Sources:

  • "Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study." Rheumatology International, 2025;45(10):243.
  • NewsRx. Study Results from Department of Internal Medicine Broaden Understanding of Rheumatoid Arthritis (Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus ...). Health & Medicine Week. October 24, 2025; p 8162.